ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)

Collins, Bridget F.; Singh, Sheetu; Joshi, Jyotsna M; Talwar, Deepak; Katiyar, Sandeep; Singh, Nishtha; Ho, Lawrence; Samaria, Jai Kumar; Bhattacharya, Pushpak; Gupta, Rakesh; Chaudhari, Sudhir; Singh, Tejraj; Moond, Vijay; Pipavath, Sudhakar; Ahuja, Jitesh; Chetambath, Ravindran; Ghoshal, Aloke Gopal; Jain, Nirmal; Joshy, Gayathri; Kant, Surya; Koul, Parvaiz A; Dhar, Raja; Swarnkar, Rajesh; Sharma, Surendra Kumar; Roy, Dhrubajyoti; Sarmah, Kripesh Ranjan; Jankharia, Bhavin; Schmidt, Rodney A.; Singh, Virendra; Raghu, Ganesh

doi:10.1183/13993003.congress-2016.pa812

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In India, chronic hypersensitivity pneumonitis (cHP), pulmonary fibrosis associated to CTD, sarcoidosis and IPF are the most common entities [24]. A more recent ILD-India registry, which collects data from 27 centers in 19 cities, reported 148 cases (14%) of IPF and 151 cases (14%) of CTD-ILD, among 1,084 patients with ILD [25]. A single-center study of 330 ILD cases from Saudi Arabia found that the most frequent disease was CTD-ILD (35%), followed by IPF (23%) and sarcoidosis (20%) [26].…”

Section: Epidemiology Of Ildmentioning

confidence: 99%

“…Relatively high levels of asbestos inhalation are required to produce asbestosis, although there are reports of asbestosis cases following moderate exposure history [35]. Accepted diagnostic criteria are based on a compatible exposure history with clinical and radiographic features (19) 76 (32) 417 (37) 287 (39) 215 (42) 234 (24) 66 (25) 32 736 (18 characteristic of asbestosis [36]. Unfortunately, a firm diagnosis may be difficult to establish, as asbestosis resembles a variety of other inflammatory and fibrotic lung diseases such as pneumoconiosis, IPF, respiratory bronchiolitis, and sarcoidosis [30].…”

Section: Asbestosmentioning

confidence: 99%

See 1 more Smart Citation

Interstitial Lung Diseases in Developing Countries

Ortega

Molina-Molina

2019

Annals of Global Health

View full text Add to dashboard Cite

More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as environmental and occupational exposures, infections, drugs, radiation, and genetic predisposition have been implicated in the pathogenesis of these conditions. Asbestosis and other pneumoconiosis, hypersensitivity pneumonitis (HP), chronic beryllium disease, and smoking-related ILD are specifically linked to inhalational exposure of environmental agents. The recent Global Burden of Disease Study reported that ILD rank 40th in relation to global years of life lost in 2013, which represents an increase of 86% compared to 1990. Idiopathic pulmonary fibrosis (IPF) is the prototype of fibrotic ILD. A recent study from the United States reported that the incidence and prevalence of IPF are 14.6 per 100,000 person-years and 58.7 per 100,000 persons, respectively. These data suggests that, in large populated areas such as Brazil, Russia, India, and China (the BRIC region), there may be approximately 2 million people living with IPF. However, studies from South America found much lower rates (0.4-1.2 cases per 100,000 per year). Limited access to highresolution computed tomography and spirometry or to multidisciplinary teams for accurate diagnosis and optimal treatment are common challenges to the management of ILD in developing countries.

show abstract

Section: Epidemiology Of Ildmentioning

confidence: 99%